Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

AKTS

Aktis Oncology, Inc.

Healthcare · USD

Set alert

Price alert · AKTS

All alert types
15.93 USD -0.92 -5.46%
As of Oct 30, 2026 Extended hours 15.93 0.00%
Bid
15.92 × 2
Ask
15.96 × 2
15.77 Day range 17.03
15.06 52-week range 32.23
YTD
-28.88%
1 year
-28.88%
Open
17.03
Prev close
16.85
Mkt cap
886.02M
Vol
251.54K
Avg vol
361.91K
EPS
-1.70
P/E
0.00
Div yield
0.00%
More statistics
Low
15.77
High
17.03
Forward P/E
-8.45
Beta
0.00
Short ratio
10.89
Inst. own
73.01%
Dividend
0.00
Ex-div date
Earnings
Nov 12, 2026
50-d avg
22.96
200-d avg
21.42
1y target
35.39

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for AKTS has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

7.16 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -18.8×
FY 2022: -43.9×FY 2023: -27.3×FY 2024: -17.8×FY 2025: -18.8×
FY 2022 5y median -23.1× FY 2025
P/S 181×
FY 2022: 0.0×FY 2023: 0.0×FY 2024: 525×FY 2025: 181×
FY 2022 5y median 90.5× FY 2025
P/B -8.0×
FY 2022: -40.6×FY 2023: -16.9×FY 2024: -8.9×FY 2025: -8.0×
FY 2022 5y median -12.9× FY 2025
P/FCF -16.0×
FY 2022: -38.2×FY 2023: -23.1×FY 2024: 65.6×FY 2025: -16.0×
FY 2022 5y median -19.5× FY 2025
EV/EBITDA -18.7×
FY 2022: -37.4×FY 2023: -27.8×FY 2024: -17.8×FY 2025: -18.7×
FY 2022 5y median -23.3× FY 2025
EV/Sales 177×
FY 2022: 0.0×FY 2023: 0.0×FY 2024: 508×FY 2025: 177×
FY 2022 5y median 88.5× FY 2025
FCF Yield -6.3%
FY 2022: -2.6%FY 2023: -4.3%FY 2024: 1.5%FY 2025: -6.3%
FY 2022 5y median -3.5% FY 2025

Profitability

Gross Margin 100.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2022 5y median 50.0% FY 2025
Operating Margin -1149.5%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: -3500.3%FY 2025: -1149.5%
FY 2022 5y median -574.8% FY 2025
Net Margin -980.9%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: -2957.6%FY 2025: -980.9%
FY 2022 5y median -490.5% FY 2025
ROE 43.6%
FY 2022: 93.2%FY 2023: 61.9%FY 2024: 50.1%FY 2025: 43.6%
FY 2022 5y median 56.0% FY 2025
ROIC -31.8%
FY 2022: -14.8%FY 2023: -29.6%FY 2024: -16.9%FY 2025: -31.8%
FY 2022 5y median -23.2% FY 2025
ROA -24.1%
FY 2022: -13.0%FY 2023: -23.4%FY 2024: -13.5%FY 2025: -24.1%
FY 2022 5y median -18.4% FY 2025

Growth (YoY)

Revenue 336.9%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 336.9%
FY 2022 FY 2025
Operating Income -43.5%
FY 2022: 0.0%FY 2023: -76.0%FY 2024: -49.6%FY 2025: -43.5%
FY 2022 FY 2025
EPS (diluted) 5.6%
FY 2022: 0.0%FY 2023: -60.8%FY 2024: -53.7%FY 2025: 5.6%
FY 2022 FY 2025
Free Cash Flow -719.4%
FY 2022: 0.0%FY 2023: -65.3%FY 2024: 135.2%FY 2025: -719.4%
FY 2022 FY 2025

Financial Health

Current Ratio 7.4×
FY 2022: 25.1×FY 2023: 16.1×FY 2024: 16.0×FY 2025: 7.4×
FY 2022 5y median 16.0× FY 2025
Quick Ratio 7.4×
FY 2022: 25.1×FY 2023: 16.1×FY 2024: 16.0×FY 2025: 7.4×
FY 2022 5y median 16.0× FY 2025
Debt / Equity -0.1×
FY 2022: -0.1×FY 2023: -0.3×FY 2024: -0.1×FY 2025: -0.1×
FY 2022 5y median -0.1× FY 2025
Net Debt / EBITDA 0.4×
FY 2022: 7.3×FY 2023: 0.6×FY 2024: 0.6×FY 2025: 0.4×
FY 2022 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2022 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31